Cargando…
The clinical genetics of phaeochromocytoma and paraganglioma
Phaeochromocytoma and paraganglioma are rare catecholamine-producing tumours, recognised to have one of the richest hereditary backgrounds of all neoplasms, with germline mutations seen in approximately 30% of patients. They can be a part of genetic syndromes such as MEN 2 or Neurofibromatosis type...
Autores principales: | Kavinga Gunawardane, P. T., Grossman, Ashley |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Sociedade Brasileira de Endocrinologia e Metabologia
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10522248/ https://www.ncbi.nlm.nih.gov/pubmed/29166454 http://dx.doi.org/10.1590/2359-3997000000299 |
Ejemplares similares
-
Predictors of outcome in phaeochromocytomas and paragangliomas
por: Nicolas, Marlo, et al.
Publicado: (2017) -
Precision Medicine in Phaeochromocytoma and Paraganglioma
por: Winzeler, Bettina, et al.
Publicado: (2021) -
Phaeochromocytomas/paragangliomas and adverse clinical outcomes in patients with Neurofibromatosis type 1
por: Al-Sharefi, A, et al.
Publicado: (2018) -
A Laboratory Medicine Perspective on the Investigation of Phaeochromocytoma and Paraganglioma
por: Boot, Christopher S.
Publicado: (2023) -
Phaeochromocytoma and Paraganglioma Excision Involving the Great Vessels
por: Srirangalingam, U., et al.
Publicado: (2017)